Chemotherapy-free strategy for platinum-sensitive recurrent ovarian cancer

Lancet Oncol. 2019 Dec;20(12):e654. doi: 10.1016/S1470-2045(19)30714-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bevacizumab
  • Female
  • Humans
  • Indazoles
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms*
  • Piperidines
  • Platinum*

Substances

  • Indazoles
  • Piperidines
  • Bevacizumab
  • Platinum
  • niraparib